Definitive Healthcare Corp
NASDAQ:DH
Intrinsic Value
Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. [ Read More ]
The intrinsic value of one DH stock under the Base Case scenario is 6.44 USD. Compared to the current market price of 6.86 USD, Definitive Healthcare Corp is Overvalued by 6%.
Valuation Backtest
Definitive Healthcare Corp
Run backtest to discover the historical profit from buying and selling DH stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Definitive Healthcare Corp
Current Assets | 393.9m |
Cash & Short-Term Investments | 308.1m |
Receivables | 59.2m |
Other Current Assets | 26.6m |
Non-Current Assets | 1.4B |
PP&E | 14.1m |
Intangibles | 1.4B |
Other Non-Current Assets | 19.7m |
Current Liabilities | 170.7m |
Accounts Payable | 5.8m |
Accrued Liabilities | 24.6m |
Other Current Liabilities | 140.3m |
Non-Current Liabilities | 793.9m |
Long-Term Debt | 242.6m |
Other Non-Current Liabilities | 551.3m |
Earnings Waterfall
Definitive Healthcare Corp
Revenue
|
251.4m
USD
|
Cost of Revenue
|
-47.5m
USD
|
Gross Profit
|
203.9m
USD
|
Operating Expenses
|
-234.8m
USD
|
Operating Income
|
-30.9m
USD
|
Other Expenses
|
-171.5m
USD
|
Net Income
|
-202.4m
USD
|
Free Cash Flow Analysis
Definitive Healthcare Corp
DH Profitability Score
Profitability Due Diligence
Definitive Healthcare Corp's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
Score
Definitive Healthcare Corp's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
DH Solvency Score
Solvency Due Diligence
Definitive Healthcare Corp's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Score
Definitive Healthcare Corp's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DH Price Targets Summary
Definitive Healthcare Corp
According to Wall Street analysts, the average 1-year price target for DH is 10.61 USD with a low forecast of 9.09 USD and a high forecast of 12.6 USD.
Ownership
DH Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
DH Price
Definitive Healthcare Corp
Average Annual Return | -47.59% |
Standard Deviation of Annual Returns | 17.85% |
Max Drawdown | -88% |
Market Capitalization | 807.6m USD |
Shares Outstanding | 117 723 000 |
Percentage of Shares Shorted | 13.67% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. The company is headquartered in Framingham, Massachusetts and currently employs 676 full-time employees. The company went IPO on 2021-09-15. The firm provides solutions through its software-as-a-service (SaaS) platform, which provides information on healthcare providers and their activities to help its customers optimize from product development to go-to-market planning and sales and marketing execution. Its platform offers Artificial Intelligence (AI) engine and Front-end SaaS platform. The firm's platform is embedded with deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. The firm provides services across biopharmaceutical and medical device companies, healthcare information technology companies, healthcare providers and other diversified companies.
Contact
IPO
Employees
Officers
The intrinsic value of one DH stock under the Base Case scenario is 6.44 USD.
Compared to the current market price of 6.86 USD, Definitive Healthcare Corp is Overvalued by 6%.